Conclusion: Adrenergic nerve control hardly affectedcochlear ischemia.
結(jié)論: 腎上腺素能神經(jīng)對(duì)內(nèi)耳缺血時(shí)耳蝸血流和血壓調(diào)節(jié)作用微弱.
互聯(lián)網(wǎng)
Adrenergic inhibitors selectively reduce sympathetic tone.
腎上腺素抑制劑有選擇地降低交感神經(jīng)的緊張度.
互聯(lián)網(wǎng)
Probably are two different kinds of the pre - and posts synaptic membranes of adrenergic nerve separately.
可能與腎上腺素能神經(jīng)突觸前膜和突觸后膜分別存在的兩類不同性質(zhì)的作用點(diǎn)有關(guān).
互聯(lián)網(wǎng)
The synthesis and technical improvement of bambutarol, an adrenergic agonistand a new antiasthma drug were reported.
報(bào)道了平喘新藥擬腎上腺素能激動(dòng)劑班布特羅的全合成及工藝改進(jìn).
互聯(lián)網(wǎng)
Additionally low arterial pressure triggers an adrenergic response with sympathetic - mediated vasoconstriction and often increased heart rate.
而且,低動(dòng)脈壓觸發(fā)腎上腺素能反應(yīng),導(dǎo)致交感神經(jīng)介導(dǎo)性血管收縮,常會(huì)使芯率加快.
互聯(lián)網(wǎng)
Conclusion Adrenergic neurotransmitters play an important role in the regulation of thyroid functions.
結(jié)論腎上腺素能神經(jīng)遞質(zhì)在甲狀腺功能的調(diào)節(jié)中扮演重要角色.
互聯(lián)網(wǎng)
The α _ 1 adrenergic receptor is also involved in the central HA pressor response.
此外,在中樞HA能的升壓作用中也有α1腎上腺素能受體的參與.
互聯(lián)網(wǎng)
OBJECTIVE : To study the synthetic method of ultra short acting ? ? adrenergic blocking agent esmolol hydrochloride.
目的: 改進(jìn)超短效β?受體阻滯劑鹽酸艾司洛爾的合成方法.
互聯(lián)網(wǎng)
AIM : To study the functional α _ 1 - adrenergic receptor ( α _ 1 - AR ) subtypes in human right gastroepiploic artery ( RGA ).
目的: 研究人右胃網(wǎng)膜動(dòng)脈 ( RGA ) 中介導(dǎo)收縮的功能性α_ 1- 腎上腺素受體 ( α_1-AR ) 亞型.
互聯(lián)網(wǎng)
Objective To investigate the effect of adrenergic neurotransmitters on the growth function of thyroid gland.
目的研究腎上腺素能神經(jīng)遞質(zhì)在甲狀腺生長(zhǎng)功能調(diào)控中的作用和意義.
互聯(lián)網(wǎng)
Objective : To observe the distribution of adrenergic fibers in adult cardiac conduction system.
目的: 觀察成人心臟傳導(dǎo)系統(tǒng)中腎上腺素能神經(jīng)纖維的分布.
互聯(lián)網(wǎng)
Pharmacologic treatment of postoperative hypertension includes usage of vasodilators, adrenergic inhibitors, and calcium channel blockers.
術(shù)后高血壓的藥物治療包括使用血管擴(kuò)張劑 、 腎上腺素抑制劑和鈣通道阻滯劑.
互聯(lián)網(wǎng)